Cyberonics Inc. – Aggressive Growth – Zacks Rank Buy
Source: http://www.zacks.com/commentary/9841/Cyberonics+Inc.+-+Aggressive+Growth+-+Zacks+Rank+BuyPosted on Sunday, January 25th, 2009 | In Stocks to Watch
The Zacks Rank Buys featured last week were: Apollo Group (APOL), Corinthian Colleges Inc. (COCO), Huron Consulting Group Inc. (HURN), and Biogen Idec Inc. (BIIB).
Cyberonics Inc. (CYBX) earnings estimates are rising since being featured as a Zacks Rank Buy in early December.
Company Description
| < ?DART(15);?> |
Cyberonics Inc. develops and markets medical devices specifically focused on neurological disorders, including epilepsy, one of the most common neurological disorders. The company uses vagus nerve stimulation through its Cyberonics NCP System to reduce the severity and frequency of seizures.
Cyberonics distributes its products in North and South America, Asia, and Europe. The Houston-based medical products company has approximately 440 employees and a market cap. of $443 million.
Estimates Rising as Report Nears
Full-year consensus estimates for both fiscal 2009 and 2010 are up over the past 90 days. The average forecast for the current year is 47 cents, up from 32 cents, a 47% increase. Estimates for 2010 are now 66 cents, up from 54 cents over the same time period.
The company is set to report third-quarter results on Feb 18. If current expectations are met, year-over-year earnings growth till be 205% and 40% in 2009 and 2010, respectively.
Given an exceptional long-term growth rate of 35% over the next 5 years, shares are trading with a PEG ratio of 1.0.
The Chart
After forming a double bottom near $10 in October and November, shares of CYBX started to climb steadily. Take a look at the chart below.
Read the December 11th Feature Here
Last Week’s Aggressive Growth Zacks Rank Buy Stocks
Apollo Group (APOL) has just crushed Wall Street estimates and shares are setting new multi-year highs.
Corinthian Colleges Inc. (COCO) is rapidly approaching its earnings release and shares are showing bullish activity.
Huron Consulting Group Inc. (HURN) is demonstrating excellent growth prospects in 2009 following a solid third-quarter earnings announcement.
Biogen Idec Inc. (BIIB) shares continue to climb as the company’s next earnings announcement quickly approaches. Biogen is looking for its fifth consecutive surprise on Feb 6.
“CYBX” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Apollo Group;, Asia, Biogen Idec Inc., cent;, Corinthian Colleges Inc;, Cyberonics Inc, epilepsy, Europe, Houston, Huron Consulting Group Inc, neurological disorders, South America, Stocks to Watch, The Zacks Rank;, USD, wall street, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.